
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc.(AMLX)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · AMLX · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
27
近12个月
买卖比
0.04
Buy/Sell (by trades)
整体情绪
Amylyx Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AMLX 季度内部人买卖趋势
AMLX 内幕交易卖出 · AMLX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AMLX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AMLX 高管卖出股份 · AMLX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 21, 2026 | Firestone Karen Director | Purchase | 3,800 | $51K | Form 4 |
| Mar 5, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Award | 248,865 | — | Form 4 |
| Mar 5, 2026 | Mazzariello Gina Chief Legal Officer | Award | 74,660 | — | Form 4 |
| Mar 5, 2026 | FRATES JAMES M CFO | Award | 95,990 | — | Form 4 |
| Mar 5, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Award | 248,865 | — | Form 4 |
| Mar 5, 2026 | Bedrosian Camille L Chief Medical Officer | Award | 95,990 | — | Form 4 |
| Mar 2, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Sale | 29,282 | $424K | Form 4 |
| Mar 2, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Sale | 29,282 | $424K | Form 4 |
| Mar 2, 2026 | Bedrosian Camille L Chief Medical Officer | Sale | 6,461 | $94K | Form 4 |
| Mar 2, 2026 | FRATES JAMES M CFO | Sale | 7,909 | $115K | Form 4 |
| Mar 2, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 6,844 | $99K | Form 4 |
| Feb 23, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 3,419 | $48K | Form 4 |
| Feb 2, 2026 | FRATES JAMES M CFO | Sale | 3,557 | $52K | Form 4 |
| Feb 2, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Sale | 15,500 | $228K | Form 4 |
| Feb 2, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 3,448 | $51K | Form 4 |
| Feb 2, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Sale | 15,500 | $228K | Form 4 |
| Jan 15, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Option | 197,182 | $1.49M⚡ | Form 4 |
| Jan 16, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Option | 2,818 | $21K | Form 4 |
| Jan 16, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Sale | 1,974 | $27K | Form 4 |
| Jan 15, 2026 | Cohen Joshua B Co-Chief Executive Officer · Director | Sale | 136,193 | $1.85M⚡ | Form 4 |
| Jan 15, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Option | 197,153 | $1.49M⚡ | Form 4 |
| Jan 16, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Option | 2,847 | $22K | Form 4 |
| Jan 16, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Sale | 1,995 | $28K | Form 4 |
| Jan 15, 2026 | Klee Justin B. Co-Chief Executive Officer · Director | Sale | 136,193 | $1.85M⚡ | Form 4 |
| Jan 12, 2026 | MILNE GEORGE M JR Director | Gift | 17,780 | — | Form 4 |
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Mar 5
股数
248,865
均价
—
总金额
—
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Mar 5
股数
248,865
均价
—
总金额
—
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Mar 2
股数
29,282
均价
$14.47
总金额
$424K
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Mar 2
股数
29,282
均价
$14.48
总金额
$424K
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Feb 2
股数
15,500
均价
$14.68
总金额
$228K
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Feb 2
股数
15,500
均价
$14.69
总金额
$228K
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Jan 15
股数
197,182
均价
$7.57
总金额
$1.49M ⚡
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Jan 16
股数
2,818
均价
$7.57
总金额
$21K
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Jan 16
股数
1,974
均价
$13.83
总金额
$27K
Cohen Joshua B
Co-Chief Executive Officer · Director
日期
Jan 15
股数
136,193
均价
$13.59
总金额
$1.85M ⚡
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Jan 15
股数
197,153
均价
$7.57
总金额
$1.49M ⚡
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Jan 16
股数
2,847
均价
$7.57
总金额
$22K
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Jan 16
股数
1,995
均价
$13.89
总金额
$28K
Klee Justin B.
Co-Chief Executive Officer · Director
日期
Jan 15
股数
136,193
均价
$13.58
总金额
$1.85M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AMLX 内幕交易
AMLX 内幕交易
Amylyx Pharmaceuticals, Inc.(AMLX)内幕交易数据来源于公司内部人(包括Cohen Joshua B (Co-Chief Executive Officer · Director), Klee Justin B. (Co-Chief Executive Officer · Director), Mazzariello Gina (Chief Legal Officer))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。AMLX内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Amylyx Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
AMLX 内幕交易 · 5个问题Amylyx Pharmaceuticals, Inc.(AMLX)的内部人包括高管和董事,如Cohen Joshua B (Co-Chief Executive Officer · Director), Klee Justin B. (Co-Chief Executive Officer · Director), Mazzariello Gina (Chief Legal Officer)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026